Literature DB >> 24950902

Clinical characteristics of Parkinson's disease patients in Greece: a multicenter, nation-wide, cross-sectional study.

Spiridon Konitsiotis1, Sevasti Bostantjopoulou2, Maria Chondrogiorgi3, Zoe Katsarou4, Georgios Tagaris5, Ioannis Mavromatis6, Evangelia E Ntzani7, Georgios Mentenopoulos8.   

Abstract

Parkinson's disease is a neurodegenerative disease, with a constantly increasing prevalence and a high global financial impact arising from direct and indirect costs. Large-scale, observational studies provide data that support the better comprehension of disease aspects, constitute a baseline reference for future studies and assist comparisons among different patient populations, allowing the recognition of distinctive characteristics and special needs. The present study is the first to depict the clinical characteristics and their interplay in a large sample of Parkinson's disease (PD) patients in Greece. Nine hundred eighty six consecutive PD outpatients were recruited from 17 centers around Greece in the time period from 8/2007 to 7/2009 and were examined and interviewed by movement disorders experts. Multiple clinical characteristics were recorded including age at diagnosis, disease severity, patients' self classification of PD symptoms and their relevance to physician's global clinical impression, smoking, alcohol consumption, presence of family history for PD, dementia, depression, hypertension, cancer and other comorbidities. Associations of high clinical significance were found between certain clinical characteristics.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Comorbidities; Cross-sectional; Multi center; Nation-wide; Parkinson's disease

Mesh:

Year:  2014        PMID: 24950902     DOI: 10.1016/j.jns.2014.05.003

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

Review 1.  Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation.

Authors:  Vivek Singh; Saba Ubaid
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

2.  Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease.

Authors:  Davide L Vetrano; Maria S Pisciotta; Vincenzo Brandi; Maria R Lo Monaco; Alice Laudisio; Graziano Onder; Domenico Fusco; Paolo D L'Angiocola; Anna R Bentivoglio; Roberto Bernabei; Giuseppe Zuccalà
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-02       Impact factor: 3.738

3.  Comorbidity burden of patients with Parkinson's disease and Parkinsonism between 2003 and 2012: A multicentre, nationwide, retrospective study in China.

Authors:  Xin Wang; Fan Zeng; Wang-Sheng Jin; Chi Zhu; Qing-Hua Wang; Xian-Le Bu; Hong-Bo Luo; Hai-Qiang Zou; Jie Pu; Zhong-He Zhou; Xiao-Ping Cui; Qing-Song Wang; Xiang-Qun Shi; Wei Han; Qiang Wu; Hui-Sheng Chen; Hang Lin; Li-Li Zhang; Meng Zhang; Yan Lian; Zhi-Qiang Xu; Hua-Dong Zhou; Tao Zhang; Yan-Jiang Wang
Journal:  Sci Rep       Date:  2017-05-10       Impact factor: 4.379

4.  Conditions Associated with Essential Tremor in Veterans: A Potential Role for Chronic Stress.

Authors:  Adrian Handforth; Gail A Parker
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-05-17

5.  Evaluation and validation of a patient-reported quality-of-life questionnaire for Parkinson's disease.

Authors:  Pantelis Stathis; George Papadopoulos
Journal:  J Patient Rep Outcomes       Date:  2022-03-02

6.  Demographic features and clinical characteristics of patients with Parkinson's disease in Isfahan, Iran.

Authors:  Mehri Salari; Omid Mirmosayyeb; Masoud Etemadifar; Vahid Shaygannejad; Fariborz Khorvash; Mohammad Reza Najafi; Fereshteh Ashtari; Ahmad Chitsaz
Journal:  Iran J Neurol       Date:  2018-01-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.